Effect of aleglitazar on cardiovascular outcomes after acute coronary syndrome in patients with type 2 diabetes mellitus: the AleCardio randomized clinical trial - Lincoff, A M; Tardif, J C; Schwartz, G G; AleCardio Investigators (JAMA, 2014)